Literature DB >> 10115851

Successful implementation of a guideline program for the rational use of lipid-lowering drugs.

M E Stuart1, M A Handley, M A Chamberlain, R W Wallach, P M Penna, A Stergachis.   

Abstract

Following the National Cholesterol Educational Program's (NCEP) 1988 screening and treatment recommendations, an educational and behavior-change program at Group Health Cooperative of Puget Sound (GHC) was developed to guide the use of lipid-lowering drugs within the larger context of cardiac risk reduction. The program has been successful in advancing a rational program to enhance care and manage costs of the use of lipid-lowering agents at GHC. Cost savings have been significant over the past two years. The educational design of the program includes training and ongoing education of a core group of "lipid gurus," who educate colleagues in area medical centers in a rational approach to hyperlipidemia. Patient education and patient participation in decision-making was emphasized. Program evaluation has demonstrated that physicians and patients are satisfied with the program, and inappropriate drug expenditures have been prevented. Key elements of the program include a critical review of outcome studies in the medical literature, use of information systems, algorithms and written materials organized into a well-designed, ongoing educational program, and development of a core group of physicians and pharmacists to administer the program at the clinic level.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 10115851

Source DB:  PubMed          Journal:  HMO Pract        ISSN: 0891-6624


  3 in total

1.  Managed care and chronic illness: health services research needs.

Authors:  E H Wagner
Journal:  Health Serv Res       Date:  1997-12       Impact factor: 3.402

2.  Assessment of chronic illness care (ACIC): a practical tool to measure quality improvement.

Authors:  Amy E Bonomi; Edward H Wagner; Russell E Glasgow; Michael VonKorff
Journal:  Health Serv Res       Date:  2002-06       Impact factor: 3.402

3.  Cost-effectiveness and Economic Benefit of Continuous Professional Development for Drug Prescribing: A Systematic Review.

Authors:  David A Cook; Christopher R Stephenson; John M Wilkinson; Stephen Maloney; Jonathan Foo
Journal:  JAMA Netw Open       Date:  2022-01-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.